Crossmark

Longitudinal evaluation of dehydroepiandrosterone (DHEA), its sulfated form and estradiol with cancer-related cognitive impairment in early-stage breast cancer patients receiving chemotherapy

Crossref DOI link: https://doi.org/10.1038/s41598-022-20420-3

Published Online: 2022-10-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Toh, Yi Long

Tan, Chia Jie

Yap, Ning Yi

Parajuli, Ritesh

Lau, Aik Jiang

Chan, Alexandre
Funding

Funding for this research was provided by:

National Medical Research Council (NMRC/CIRG/1386/2014)
License Information

Text and Data Mining valid from 2022-10-03

Version of Record valid from 2022-10-03
More Information

Article History

Received: 24 June 2022

Accepted: 13 September 2022

First Online: 3 October 2022

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below